Dermatology Topics Topic page Drugs News Journals Guidelines Clinical Trials Knowledge Centres Drug Data
Content on this page Clabin® plus Description, Presentation and Dosage Clabin® plus Precautions, Reactions and Contraindications Related Information
Related News EU Pharmacovigilance Risk Assessment Committee clears Diane 35 (Bayer) for Acne Read more CHMP recommends Erivedge (Roche) for treatment of Basal Cell Carcinoma Read more Picato(Leo Pharma) fails IQWiG assessment for Actinic Keratosis in Germany Read more Positive Phase III results for tedizolid phosphate (Trius Therapeutics) for ABSSSI Read more Phase IIa trial of AFN 1252 (Affinium Pharma) shows drug is effective and safe against Bacterial Infections Read more Study shows Picato (Leo Pharma) provides sustained clearance of Actinic Keratosis at 12 months Read more Phase III success for talimogene laherparepvec (Amgen) in Melanoma Read more Study suggests omega-3 fish oil can help protect against Skin Cancer Read more Dalbavancin (Durata Therapeutics) success in Phase III DISCOVER 2 trial for ABSSSI Read more New Phase III trial results of Xolair (Genentech/Roche/Novartis) for patients with Urticaria Read more
Recent Updates Drugs Read more RMS-PETRASCH TROPFEN Read more LOKALISON ANTIMIKROBIELL CREME N Read more BIOPLANT®-KAMILLENFLUID Read more FUCIDINE® PLUS SALBE Read more PRIORIN® View all Clinical Guidelines Read more British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009 Read more Guidelines for Eczema (syn. Dermatitis) Read more Guidelines for Psoriasis Read more Guidelines for Viral Warts View all Medical Journals Read more Epidemiology and clinical characteristics of bullous congenital ichthyosiform erythroderma (keratinolytic ichthyosis) in Japan: Results from a nationwide survey Read more Unknown primary Merkel cell carcinoma: 23 new cases and a review Read more Skin cancer surveillance behaviors among US Hispanic adults Read more Pregnancy and dermatologic therapy